Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

1622000

USP

Stearyl alcohol

United States Pharmacopeia (USP) Reference Standard

Synonyme(s) :

1-Octadecanol, Octadecyl alcohol, Stearyl alcohol

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Formule linéaire :
CH3(CH2)17OH
Numéro CAS:
Poids moléculaire :
270.49
Numéro Beilstein :
1362907
Numéro MDL:
Code UNSPSC :
41116107
ID de substance PubChem :
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Densité de vapeur

9.3 (vs air)

Pression de vapeur

<0.01 mmHg ( 38 °C)

Famille d'API

stearyl alcohol

Température d'inflammation spontanée

842 °F

Limite d'explosivité

~8 %

Fabricant/nom de marque

USP

Pf

56-59 °C (lit.)

Densité

0.812 g/mL at 25 °C (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Chaîne SMILES 

CCCCCCCCCCCCCCCCCCO

InChI

1S/C18H38O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h19H,2-18H2,1H3

Clé InChI

GLDOVTGHNKAZLK-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Stearyl alcohol USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Cetostearyl Alcohol
  • Sodium Stearyl Fumarate
  • Hydrogenated Lanolin
  • Cetyl Alcohol
  • Myristyl Alcohol
  • Oleyl Alcohol

Remarque sur l'analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

nwg

Point d'éclair (°F)

383.0 °F - closed cup

Point d'éclair (°C)

195 °C - closed cup


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

A Carpio et al.
Journal of chromatography. A, 1370, 25-32 (2014-12-03)
A periodic mesoporous organosilica, in particular, a phenylene-bridged material (Ph-PMO), was evaluated for the first time as a sorbent for retaining and eluting fenuron, simazine, atrazine, carbaryl and terbutryn in grape must by solid phase extraction (SPE) prior to their
Xiaole Qi et al.
The Journal of pharmacy and pharmacology, 67(4), 493-500 (2014-12-17)
The aim of this study was to prepare a disintegrating gastric floating tablet composed of floating pellets coated with acrylic resin to prolong the gastric residence time and increase the oral bioavailability of famotidine. The gastric floating pellets containing famotidine
Aly Ahmed Abdelbary et al.
Drug delivery, 22(1), 37-49 (2013-12-20)
Famotidine HCl has low bioavailability (40-45%) due to its narrow absorption window and low solubility in intestinal pH. Lipids were utilized in the formulation of novel gastroretentive dosage forms to increase the availability of famotidine HCl at its absorption site.
Deirdre A Costello et al.
Journal of virology, 89(1), 350-360 (2014-10-17)
Influenza A virus strains adapt to achieve successful entry into host species. Entry is mediated by the viral membrane protein hemagglutinin (HA), which triggers membrane fusion and genome release under acidic conditions in the endosome. In addition to changes in
Kay Marquardt et al.
International journal of pharmaceutics, 479(1), 150-158 (2014-12-30)
RNA-cleaving DNAzymes are a potential novel class of nucleic acid-based active pharmaceutical ingredients (API). However, developing an appropriate drug delivery system (DDS) that achieves high bioavailability is challenging. Especially in a dermal application, DNAzymes have to overcome physiological barriers composed

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique